Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Donate to our blog

Your support will help Science & Enterprise continue to provide science news for business people and business news for scientists.

Heart Assoc, Amazon Partner on Precision Medicine Data

American Heart Association and Amazon Web Services are collecting data from researchers to advance precision medicine in cardiovascular diseases and stroke. . . . → Read More: Heart Assoc, Amazon Partner on Precision Medicine Data

Patent Issued for Peptides in Diabetes Gene Therapy

A U.S. patent was issued today for synthetic peptides that support gene therapies developed to treat type 2 diabetes and heart failure. . . . → Read More: Patent Issued for Peptides in Diabetes Gene Therapy

Low-Dose Multidrug Shown Effective in Hypertension Trial

A small-scale clinical trial shows a combination of four current drugs to treat hypertension, or high blood pressure, formulated in low doses, reduces blood pressure to normal levels in four weeks. . . . → Read More: Low-Dose Multidrug Shown Effective in Hypertension Trial

Company, NC State Partner on Tissue Oxygen Patch

Profusa Inc. and a research center at North Carolina State University are developing a new device to monitor tissue oxygen levels in people with peripheral artery disease. . . . → Read More: Company, NC State Partner on Tissue Oxygen Patch

EU Project to Develop More Versatile Heart Pacemakers

An initiative in Europe plans to design a new type of pacemaker device that adapts to a host of signals in the cardiovascular system and regulates multiple heart functions. . . . → Read More: EU Project to Develop More Versatile Heart Pacemakers

Lilly Acquires Migraine Therapy Company in $960M Deal

Drug maker Eli Lilly and Company is acquiring CoLucid Pharmaceuticals, a developer of treatments for migraine pain and associated symptoms. . . . → Read More: Lilly Acquires Migraine Therapy Company in $960M Deal

Pharma Firms Start Non-Communicable Disease Initiative

A group of 22 pharmaceutical companies is supporting worldwide projects to improve access to prevention and treatments for chronic disorders like cancer and heart disease, in lower-resource regions. . . . → Read More: Pharma Firms Start Non-Communicable Disease Initiative

Ionis Options Cardiac Drugs in $1.5 Billion Deal

Biotechnology company Ionis Pharmaceuticals is providing drug maker Novartis first access to two experimental drugs for controlling proteins that promote cholesterol and triglycerides, which contribute to heart disease. . . . → Read More: Ionis Options Cardiac Drugs in $1.5 Billion Deal

Solar Cells Shown Feasible to Power Medical Implants

Biomedical engineers in Switzerland built and field-tested small solar cells that generated enough energy for implanted medical devices like heart pacemakers. . . . → Read More: Solar Cells Shown Feasible to Power Medical Implants

Trial to Test Stem Cells for Treating Heart Failure

A clinical trial testing a treatment for heart failure using a patient’s own bone marrow stem cells is recruiting participants at the first two study sites. . . . → Read More: Trial to Test Stem Cells for Treating Heart Failure